D. E. Shaw & Co »

Alnylam Pharmaceuticals shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2013-03-31 $7.1M 293k 24.37
2012-12-31 $2.1M 113k 18.25
2012-06-30 $1.8M 157k 11.67
2012-03-31 $1.4M 126k 11.06

More positions owned by D. E. Shaw & Co

Microsoft Corporation Put Option (MSFT)
Apple Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A Call Option (META)
Booking Holdings (BKNG)
Netflix Put Option (NFLX)
Advanced Micro Devices Put Option (AMD)
Chipotle Mexican Grill (CMG)
Tesla Motors (TSLA)
Uber Technologies Put Option (UBER)
Exxon Mobil Corporation Put Option (XOM)
Citigroup Com New (C)
Alphabet Cap Stk Cl A (GOOGL)
Royal Caribbean Cruises Put Option (RCL)

View all positions for D. E. Shaw & Co

Top funds holding Alnylam Pharmaceuticals

Vanguard Group
Wellington Management Company
Baillie Gifford & Co
Dodge & Cox
T. Rowe Price Associates
Jpmorgan Chase & Co
Norges Bank Investment Management
venBio Select Advisor
Legal & General Group
Bellevue Group
Bank of New York Mellon
Ubs Global Asset Management Americas
Amundi
Gilder, Gagnon, Howe & Co
Alliancebernstein

View all funds holding Alnylam Pharmaceuticals